bosutinib dihydrate
SpainDrugs containing this active substance
-
Bosutinib Vivanta is used to treat adult patients with a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), whether newly diagnosed or when other treatments have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage bosutinib dihydrate 106,79 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to treat adult patients with a type of blood cancer called chronic myeloid leukemia (CML) that is Philadelphia chromosome positive (Ph-positive), either newly diagnosed or when other medications have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage bosutinib dihydrate 427,16 mg Manufacturer: Vivanta Generics S.R.O.
-
Bosutinib Vivanta is used to treat adult patients with a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), whether newly diagnosed or when other treatments have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage bosutinib dihydrate 533,95 mg Manufacturer: Vivanta Generics S.R.O.